Since 1996 Janssen Pharmaceuticals manufactured the drug Elmiron to treat patients with Interstitial Cystitis (IC), a condition that causes bladder pressure and pain. In 2015, ongoing research linked the drug Elmiron to an eye disease called maculopathy. Even with the growing mountain of evidence, Janssen Pharmaceutical has not warned the public about Elmiron’s risks.
Doctors with Interstitial Cystitis patients have generally prescribed 300 milligram doses of Elmiron per day, but sometimes, in more complicated situations, patients can be prescribed up to 1500 milligrams daily. Since 1996 millions of people have taken Elmirion, which could cause minor to complete eye damage. There is already a large number of reported cases from former users.
Debra Broz, Attorneys at Law, PLC are filing lawsuits on behalf of clients. If you have been diagnosed with maculopathy due to taking Elmiron, you may be eligible for compensation. Please don’t hesitate to contact us for your free case evaluation.
Elmiron’s risks were unknown until the Emory Eye Center in Atlanta came across a similar eye condition with six patients in 2015. The cause was uncertain for this form of maculopathy. Upon further investigation, doctors learned that every patient had taken Elmiron for many years.
Recent studies released between 2018-2019 also support Elmiron and maculopathy’s connection, yet it is still unknown how exactly the drug causes this condition.
Even with the evidence, Janssen Pharmaceuticals will not list eye disease as a side effect. Every day, hundreds of thousands of patients put themselves at risk while countless others have already had an unreported eye injury.
If you have or a loved one has suffered eye damage due to taking Elmiron, then you may be entitled to compensation. We are here to fight for what you deserve.